Cercar

25/03/2024 Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans
Padro, T, Santisteban, V, Huedo, P, Puntes, M, Aguiló, M, Espadaler-Mazo, J, Badimon, L. Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans. CARDIOVASCULAR RESEARCH. 2024; 120(7)DOI:10.1093/cvr/cvae061. PMID:38525555. IF:13.300(Q1/1D).
11/10/2023 Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units
Moraga P., Prieto P., Conradie A., Benhayoun M., Rousell V., Davy M., Fuhr U., Antonijoan Arbos R., Abad-Santos F., Portolés A., Van Duinen J., Carcas A.J., Borobia A.M.. Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units. CTS-Clinical and Translational Science. 2023; 16(12)DOI:10.1111/cts.13655. PMID:37818923. IF:3.100(Q2/5D).
01/02/2023 The role of opioid transmission in music-induced pleasure
Mas-Herrero, E, Ferreri, L, Cardona, G, Zatorre, RJ, Pla-Junca, F, Antonijoan, RM, Riba, J, Valle, M, Rodriguez-Fornells, A. The role of opioid transmission in music-induced pleasure. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2023; 1520(1)DOI:10.1111/nyas.14946. PMID:36514207. IF:4.100(Q1/2D).
01/01/2022 A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis
Soria J.M., Mojal S., Martinez-Perez A., Acosta F.R., López S., Miqueleiz S., Rodriguez D., Quijada M.A., Cardenas A., Vidal F., Remacha A., Antonijoan R.M., Souto J.C.. A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis. HAEMATOLOGICA. 2022; 107(9)DOI:10.3324/haematol.2022.281068. PMID:35545920. IF:10.100(Q1/2D).
01/01/2022 An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Krolewiecki A., Enbiale W., Gandasegui J., van Lieshout L., Kepha S., Messa Junior A., Bengtson M., Gelaye W., Escola V., Martinez-Valladares M., Cambra-Pellejà M., Algorta J., Martí-Soler H., Fleitas P., Ballester M.R., Doyle S.R., Williams N.A., Legarda A., Mandomando I., Mwandawiro C., Muñoz J.. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates Open Research. 2022; 6DOI:10.12688/gatesopenres.13615.1. PMID:. IF:(Q/D).
01/04/2023 Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults
De la Serna, E, Puig, O, Mezquida, G, Moreno-Izco, L, Merchan-Naranjo, J, Amoretti, S, Ruiz, P, Gonzalez-Pinto, A, Molina-Garcia, M, Corripio, I, Vieta, E, Baeza, I, Berge, D, Penades, R, Sanchez-Torres, A, Cuesta, MJ, Bernardo, M, Castro-Fornieles, J. Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2023; 32(4)DOI:10.1007/s00787-021-01901-8. PMID:34714406. IF:6.000(Q1/1D).
10/01/2022 Target selection for deep brain stimulation in treatment resistant schizophrenia
Corripio, I, Roldan, A, McKenna, P, Sarro, S, Alonso-Solis, A, Salgado, L, Alvarez, E, Molet, J, Pomarol-Clotet, E, Portella, M. Target selection for deep brain stimulation in treatment resistant schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2022; 112DOI:10.1016/j.pnpbp.2021.110436. PMID:34517055. IF:5.600(Q1/2D).
01/01/2022 Ayahuasca may help to improve self-compassion and self-criticism capacities
Dominguez-Clave, E, Soler, J, Elices, M, Franquesa, A, Alvarez, E, Pascual, JC. Ayahuasca may help to improve self-compassion and self-criticism capacities. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2022; 37(1)DOI:10.1002/hup.2807. PMID:34411343. IF:1.700(Q3/8D).